The LILRA4 gene helps control immune cells that send early antiviral signals and alert the rest of the immune system. This gene plays an important role in keeping those signals balanced, so inflammation does not become harder to control. If LILRA4 does not work properly, immune responses may become less well regulated, which can affect how the body handles infections and may contribute to inflammatory or autoimmune conditions in some people.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
LILRA4Gene function
What if the gene works
The LILRA4 gene helps certain immune cells sense signals from nearby cells. This helps control interferon release, which can keep immune responses more balanced and limit unnecessary inflammation.
Risk
What if the gene does not work
Variants in the LILRA4 gene can range from milder to more severe and may reduce or disrupt the ILT7 receptor on certain immune cells. This can weaken signals that normally help control interferon, an antiviral immune messenger.
Treatment
What does that mean for your treatment
No LILRA4-specific treatment or management approach is currently established in clinical guidelines. The LILRA4 gene is mainly being studied as an immune cell marker, including in blastic plasmacytoid dendritic cell neoplasm, rather than as a guide for current drug choice.
Gene function
What if the gene works
Your immune system needs careful timing so it can react to viruses without overdoing the response. The LILRA4 gene is mainly active in plasmacytoid dendritic cells, a group of immune cells that help launch early antiviral defenses. This matters for how the LILRA4 gene helps control interferon release in plasmacytoid dendritic cells and keep immune signaling measured.
In plasmacytoid dendritic cells, the LILRA4 gene provides a built in braking signal. When this receptor is engaged, it helps these cells tone down some activation signals and respond in a more controlled way.
One of its main roles is to limit type I interferon, a key antiviral alarm signal. This helps the body release that signal with better timing and keeps normal immune communication more balanced.
Its protein sits on the cell surface, where it receives messages from nearby cells by binding a partner protein called BST2. That contact helps immune cells coordinate with each other during routine surveillance and early responses to infection.
The LILRA4 receptor passes its message inward through a helper protein called FCER1G. This relay lets outside cell contact shape how the cell sends cytokines, which are chemical messages used by the immune system.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LILRA4 gene can alter the receptor’s shape, stability, or ability to reach the cell surface. In discussions of LILRA4 gene variants and protein function, milder changes may only partly weaken binding or cell signaling, while more disruptive variants can greatly reduce signaling or stop the receptor from being made at all. Some variants also disrupt RNA splicing, the editing step that helps build the final protein, which can leave it shortened or unstable.
How variants are linked to conditions
Current evidence on how LILRA4 gene variants are linked to conditions is still developing. The LILRA4 gene does not yet have a broadly confirmed link to a specific health condition in routine clinical genetics. Research findings may evolve over time. Anyone with a confirmed LILRA4-related diagnosis should follow advice from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Human biology normally includes genetic variants, and they are widely found across the population. Most do not directly affect health and simply contribute to natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. There are cases, though, where one well-characterized variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LILRA4 gene. If a test finds a change in LILRA4, its meaning usually depends on the exact change and the wider clinical picture.
Inheritance of LILRA4 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the inheritance of LILRA4 gene variants, and this picture may become clearer as research grows. The LILRA4 gene is on chromosome 19, which is an autosome, so a person inherits one copy from each parent. That means any LILRA4 variant can be passed through either side of the family, but a single well established dominant or recessive pattern has not been defined for a specific LILRA4 related condition.
What does my LILRA4 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking the LILRA4 gene to a specific genetic condition in families. If you have a LILRA4 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact result and health history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for LILRA4 variants usually reads the DNA code in the LILRA4 gene from a blood sample, saliva sample, or cheek swab. A lab compares your sequence with a reference and reports whether a variant is found. Results may show a known variant, no variant, or a change with unclear health meaning.
When should I consider getting a genetic test?
There is not yet a widely established, LILRA4-specific medical reason for genetic testing. Decisions about testing are best made with a doctor or genetics specialist, based on your personal health and family history.
A genetic result is only one part of your health story
Genetic results can be very informative, but the amount they reveal varies with the condition and the kind of variant found. How your body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides added context rather than a definite answer and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic finding can offer a clear explanation. In areas like medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more quickly, while others process it more slowly or are more sensitive to its effects. This helps explain why the same treatment can work well for one person but less well for another, or why side effects can differ. These differences are common and are one part of how care can be matched more closely to each person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more personalized. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the LILRA4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about treatment, side effects, or new symptoms are best discussed with your doctor.